SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CCEL

Cryo Cell International Inc (CCEL)

NYSE: CCEL · USD
Healthcare · Medical Care Facilities
$4.63+$0.08 (+1.76%)
 
Market cap
$37.3M
Insider Score
Market Cap$37.33M+14.0%
Revenue (ttm)$31.13M
Net Income-$1.95M
EPS-$0.24
Shares Out8.06M
PE Ration/a
Forward PE231.50
Dividend$0.60(0.00%)
Ex-Dividend DateMay 21, 2025
Volume18,952
Open$4.52
Previous Close$4.55
Day's Range$4.18 - $4.75
52-Week Range$2.72 - $5.45
Beta0.55
Analystsnone
Price Targetn/a
Earnings Daten/a
+1.76% (1D)
No price history available.

About CCEL

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Address
700 Brooker Creek Boulevard, Oldsmar, FL, 34677, United States
Market Cap
37 million
Employees
72
Industrial Classification
Medical Care Facilities
1 Day
+1.76%
5 Days
-4.93%
1 Month
-0.43%
6 Months
+31.91%
1 Year
+14.04%

$CCEL stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CCEL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CCEL's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CCEL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CCEL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CCEL from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from CCEL’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.